Healthcare Capital this morning said its stockholders voted in favor of combining with Alpha Tau Medical Ltd., an Israel-based medical device company.
The SPAC in a news release said 94.57% of the votes cast at the meeting, representing approximately 65.64% of HCCC’s outstanding shares, voted to approve the deal.
Healthcare Capital last week convened and adjourned shareholder meetings twice without calling for a vote on the transaction. The SPAC in SEC filings said it needed more time to meet the requirements to close the deal, which has a minimum cash condition of $225 million.
The news release this morning did not reveal redemption figures, if any, and the SPAC has not filed any information with the SEC since the merger vote.
Upon closing, Alpha Tau Medical shares and warrants are expected to trade on the Nasdaq under the new symbols DRTS and DRTSW. Read more.
